Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 2 Cellular pathways implicated in CIPN

Published byAudrey Beasley Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 2 Cellular pathways implicated in CIPN"— Presentation transcript:

1 Figure 2 Cellular pathways implicated in CIPN
Figure 2 | Cellular pathways implicated in CIPN. Candidate genes investigated in most of the studies performed so far are mainly related to the metabolism and transport of chemotherapy drugs or to DNA repair. Other pathways and processes that might be implicated in chemotherapy-induced neuropathy (CIPN) include cell adhesion, energy production and redox homeostasis. Clear understanding of how these processes contribute to CIPN is currently lacking. Argyriou A. A. et al. (2017) Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Figure 2 Cellular pathways implicated in CIPN"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.

Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Figure 2 Systemic abnormalities in AD

Figure 2 Systemic abnormalities in AD
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes

Figure 4 Time course of the development of physiological changes
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Monoamine synthesis and metabolism in neurons

Figure 2 Monoamine synthesis and metabolism in neurons
Figure 1 Factors underlying metabolic alterations in osteoarthritis

Figure 1 Factors underlying metabolic alterations in osteoarthritis
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Candidate signalling pathways of irisin in adipocytes

Figure 1 Candidate signalling pathways of irisin in adipocytes
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Similar presentations

Ads by Google